Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcin Okroj

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Cancer Treatment Reviews|December 11, 2012
Effector mechanisms of anti-CD20 monoclonal antibodies in B cell malignanciesMarcin Okroj, Anders Österborg, Anna M Blom
Annals of Medicine|September 14, 2007
Rheumatoid arthritis and the complement systemMarcin Okroj, Dick Heinegård, Rikard Holmdahl, et al.
Medical Oncology (Northwood, London, England)|November 8, 2013
Killing of CLL and NHL cells by rituximab and ofatumumab under limited availability of complementMarcin Okroj, Ingrid Eriksson, Anders Österborg, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 14, 2013
Sushi domain-containing protein 4 (SUSD4) inhibits complement by disrupting the formation of the classical C3 convertaseEmelie Holmquist, Marcin Okroj, Björn Nodin, et al.
Molecular Immunology|March 22, 2015
Antibodies reactive to cleaved sites in complement proteins enable highly specific measurement of soluble markers of complement activationAnna M Blom, Anders Österborg, Tom E Mollnes, et al.
Plos One|October 17, 2012
Functional analyses of complement convertases using C3 and C5-depleted seraMarcin Okroj, Emelie Holmquist, Ben C King, et al.
Cancer Immunology, Immunotherapy : CII|March 5, 2009
Hypoxia increases susceptibility of non-small cell lung cancer cells to complement attackMarcin Okroj, Leticia Corrales, Anna Stokowska, et al.
Molecular Immunology|June 6, 2007
Non-small cell lung cancer cells produce a functional set of complement factor I and its soluble cofactorsMarcin Okroj, Yi-Fan Hsu, Daniel Ajona, et al.
Molecular Immunology|August 22, 2008
Structural basis and functional effects of the interaction between complement inhibitor C4b-binding protein and DNAMarcin Okroj, Huw T Jenkins, Andrew P Herbert, et al.
Cancer Immunology, Immunotherapy : CII|January 26, 2015
Local expression of complement factor I in breast cancer cells correlates with poor survival and recurrenceMarcin Okroj, Emelie Holmquist, Elise Nilsson, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Cancer Treatment Reviews|December 11, 2012
Effector mechanisms of anti-CD20 monoclonal antibodies in B cell malignanciesMarcin Okroj, Anders Österborg, Anna M Blom
Annals of Medicine|September 14, 2007
Rheumatoid arthritis and the complement systemMarcin Okroj, Dick Heinegård, Rikard Holmdahl, et al.
Medical Oncology (Northwood, London, England)|November 8, 2013
Killing of CLL and NHL cells by rituximab and ofatumumab under limited availability of complementMarcin Okroj, Ingrid Eriksson, Anders Österborg, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 14, 2013
Sushi domain-containing protein 4 (SUSD4) inhibits complement by disrupting the formation of the classical C3 convertaseEmelie Holmquist, Marcin Okroj, Björn Nodin, et al.
Molecular Immunology|March 22, 2015
Antibodies reactive to cleaved sites in complement proteins enable highly specific measurement of soluble markers of complement activationAnna M Blom, Anders Österborg, Tom E Mollnes, et al.
Plos One|October 17, 2012
Functional analyses of complement convertases using C3 and C5-depleted seraMarcin Okroj, Emelie Holmquist, Ben C King, et al.
Cancer Immunology, Immunotherapy : CII|March 5, 2009
Hypoxia increases susceptibility of non-small cell lung cancer cells to complement attackMarcin Okroj, Leticia Corrales, Anna Stokowska, et al.
Molecular Immunology|June 6, 2007
Non-small cell lung cancer cells produce a functional set of complement factor I and its soluble cofactorsMarcin Okroj, Yi-Fan Hsu, Daniel Ajona, et al.
Molecular Immunology|August 22, 2008
Structural basis and functional effects of the interaction between complement inhibitor C4b-binding protein and DNAMarcin Okroj, Huw T Jenkins, Andrew P Herbert, et al.
Cancer Immunology, Immunotherapy : CII|January 26, 2015
Local expression of complement factor I in breast cancer cells correlates with poor survival and recurrenceMarcin Okroj, Emelie Holmquist, Elise Nilsson, et al.
Pageof 3